We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Chemotherapeutic agents against RNA viruses: ranks swelling

JAMA. 1983;249(8):989-991. doi:10.1001/jama.1983.03330320003001.
Text Size: A A A
Published online


The first antiviral agent licensed by the Food and Drug Administration for systemic use in the United States (October 1966) was amantadine hydrochloride, an agent that blocks infection by influenza A (and some influenza B) strains.

Yet, as recently as the influenza A epidemic of 1980, says R. Gordon Douglas, Jr, MD, chair of the Department of Medicine, Cornell University Medical College, New York, and physician-in-chief, New York Hospital, amantadine was not widely used due to a commonly held belief that synthetic agents directed against RNA viruses were not safe or effective (see accompanying story, p 991).

This attitude has begun to change. Declares Raphael Dolin, MD, professor of medicine at the University of Rochester School of Medicine and Dentistry, New York, "There are now a number of compounds that are promising, and the whole area of antiviral chemoprophylaxis is more established."

Two newer agents now in clinical trials have


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.